Back to top
more

Siga Technologies (SIGA)

(Real Time Quote from BATS)

$7.40 USD

7.40
125,284

-0.04 (-0.54%)

Updated May 31, 2024 10:26 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 250)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for SIGA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Siga Technologies Inc. [SIGA]

Reports for Purchase

Showing records 41 - 60 ( 77 total )

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 41

05/28/2013

Company Report

Pages: 7

Favorable Supreme Court Appeal Ruling, Raising Price Target to $11 - Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 42

05/12/2013

Daily Note

Pages: 4

Announces Restatement of Financial Results - Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 43

05/07/2013

Daily Note

Pages: 5

Q1:13 Update - 190K Courses of Arestvyr Shipped - Financials Pending - Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 44

05/03/2013

Industry Report

Pages: 5

LIFE SCIENCES-The Week Ahead in Life Sciences - Upcoming Events for the Week of May 6

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 45

03/11/2013

Daily Note

Pages: 4

GAAP Accounting Treatment of Arestvyr Sales Expected to Delay PIP Payments Until FDA Approval - Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 46

03/07/2013

Company Report

Pages: 6

Q4:12 Financial Results - We Expect a Favorable Supreme Court Appeal Ruling, Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 47

02/26/2013

Daily Note

Pages: 4

Revising Delaware Court Decision Timing To Imminent - Reiterate OUTPERFORM.

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 48

02/07/2013

Daily Note

Pages: 7

Learnings from our Sector Insights Call with Judge Farnan - Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 49

11/06/2012

Company Report

Pages: 6

Lowering Price Target to $7.50, Q3:12 EPS, ST-246 on Schedule for First Deliveries in Q1:13, Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 50

08/07/2012

Company Report

Pages: 5

Q2:12 EPS, ST-246 on Schedule for First Deliveries in Q1:13, Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 51

06/06/2012

Company Report

Pages: 6

Definition of "Net Profits" Means Payments to PIP to Occur Later Than Anticipated in Q3:2013 - Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 52

06/05/2012

Industry Report

Pages: 40

June 2012 Potential Catalysts & Milestones - Monthly Update

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 53

05/07/2012

Company Report

Pages: 6

Q1:12 Update - Next Up, $12 Million Milestone Payment for a Product-Labeling Plan in Mid-2012

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 54

03/05/2012

Company Report

Pages: 6

Q4:11 Update - ST-246 Commercial Sales to Start Q1:13

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 55

11/18/2011

Company Report

Pages: 7

Quarterly Update: SIGA Receives $41-Million Milestone Payment, ST-246 Production Started First Deliveries Q1:13

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 56

09/23/2011

Company Report

Pages: 6

Parsons Rules 50% Profit Sharing on ST-246 - First Sales in Q3:12 - OUTPERFORM but Lowering PT to $11

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 57

08/24/2011

Daily Note

Pages: 4

Grant for Arena Virus Supports Pipeline - Next Event - Decision in PIP Litigation

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 58

08/01/2011

Industry Report

Pages: 20

August 2011 Potential Milestones & Key Events - Monthly Update

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 50.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 59

08/01/2011

Company Report

Pages: 8

Q2:11 Update - Litigation Outcome Next Catalyst, ST-246 Remains on Track for Sales in Q3:12

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Siga Technologies Inc.

Industry: Medical - Drugs

Record: 60

07/19/2011

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for SIGA

Provider: VALUENGINE, INC

Price: 25.00

Research Provided by a Third Party